LP
CTV.WS

LMR Partners’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

LMR Partners’s Portfolio CTV.WS Stock Details CTV.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,057,495
Closed -$116K – 1718
2024
Q4 		$116K Buy
+1,057,495
New +$85.3K ﹤0.01% 986
2024
Q3 		– Sell
-1,074,838
Closed -$41.2K – 1596
2024
Q2 		$69.9K Hold
1,074,838
– – ﹤0.01% 911
2024
Q1 		$48.4K Hold
1,074,838
– – ﹤0.01% 989
2023
Q4 		$32.2K Hold
1,074,838
– – ﹤0.01% 815
2023
Q3 		$75.2K Hold
1,074,838
– – ﹤0.01% 697
2023
Q2 		$107K Hold
1,074,838
– – ﹤0.01% 617
2023
Q1 		$1.52M Hold
1,074,838
– – 0.02% 513
2022
Q4 		$1.84M Hold
1,074,838
– – 0.03% 549
2022
Q3 		$2.91M Hold
1,074,838
– – 0.05% 420
2022
Q2 		$1.78M Buy
1,074,838
+745,323
+226% +$508K 0.03% 575
2022
Q1 		$1.99M Buy
329,515
+257,278
+356% +$229K 0.02% 572
2021
Q4 		$480K Buy
+72,237
New +$89.9K ﹤0.01% 927

Other funds holding CTV.WS

AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

LMR Partners's CTV.WS Position: Q1 2025 in Review

LMR Partners sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q1 2025, closing a stake of 1,057,495 shares — an estimated $116K sold.

LMR Partners first reported a position in CTV.WS in Q4 2021 and held it in 12 quarters. The position peaked at $2.91M in Q3 2022. 1 fund tracked by Wall St. Rank holds CTV.WS as of Q1 2025.

  • LMR Partners reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q1 2025 after selling out during the quarter.
  • LMR Partners sold 1,057,495 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q1 2025, an estimated $116K.
  • LMR Partners first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 12 quarters.
  • LMR Partners's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $2.91M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q1 2025.

Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.